TERT promoter mutations in primary and secondary WHO grade III meningioma-Reference-Cited by-同舟云学术

TERT promoter mutations in primary and secondary WHO grade III meningioma

Published:2020-09-15 Issue:1 Volume:31 Page:61-69
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathol.

Author:

Maier Andrea Daniela¹²^ORCID,Stenman Adam³⁴⁵,Svahn Fredrika³,Mirian Christian¹^ORCID,Bartek Jiri¹⁶⁷,Juhler Marianne¹,Zedenius Jan⁴⁵,Broholm Helle²,Mathiesen Tiit¹⁷⁸

Affiliation:

1. Department of Neurosurgery Copenhagen University HospitalRigshospitalet Copenhagen Denmark

2. Department of Pathology Center of Diagnostic Investigation Copenhagen University Hospital Copenhagen Denmark

3. Department of Oncology‐Pathology Karolinska Institutet Stockholm Sweden

4. Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden

5. Department of Breast, Endocrine Tumors and Sarcoma Karolinska University Hospital Stockholm Sweden

6. Department of Neurosurgery Karolinska University Hospital Stockholm Sweden

7. Department of Clinical Neuroscience and Department of Medicine Karolinska Institutet Stockholm Sweden

8. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

Funder

Kræftens Bekæmpelse

Publisher

Wiley

Subject

Clinical Neurology,Pathology and Forensic Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bpa.12892

Reference24 articles.

1. Systematic analysis of telomere length and somatic alterations in 31 cancer types

2. Genomic landscape of high-grade meningiomas

3. High-grade meningiomas: biology and implications

4. Alterations of the Tumor Suppressor Genes CDKN2A (p16), p14, CDKN2B (p15), and CDKN2C (p18) in Atypical and Anaplastic Meningiomas

5. High Incidence of ActivatingTERTPromoter Mutations in Meningiomas Undergoing Malignant Progression

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of early recurrence in meningioma;2024-06-26

2. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection;Journal of Clinical Neuroscience;2024-06

3. A comprehensive correlation of the KI-67 proliferation index to patient´s, imaging and tumor features and its value in predicting long-term course of patients with newly diagnosed intracranial meningiomas;Neurosurgical Review;2024-05-28

4. Evaluation of prognostic biomarkers in meningiomas and their clinical implications in settings with limited resources;Neuro-Oncology Practice;2024-04-09

5. Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B status;Neuro-Oncology Advances;2024-01-01